• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Characterisation of coronary microvascular dysfunction in patients with severe aortic stenosis undergoing TAVI.经 TAVI 治疗的重度主动脉瓣狭窄患者的冠状动脉微血管功能障碍特征。
EuroIntervention. 2024 Mar 4;20(5):e289-e300. doi: 10.4244/EIJ-D-23-00735.
2
Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation.经导管主动脉瓣植入术患者的冠状动脉微血管功能障碍。
Heart. 2024 Mar 22;110(8):603-612. doi: 10.1136/heartjnl-2023-323461.
3
Proof of concept study on coronary microvascular function in low flow low gradient aortic stenosis.低流量低跨瓣压差主动脉瓣狭窄患者冠状动脉微血管功能的概念验证研究
Heart. 2023 Apr 25;109(10):785-793. doi: 10.1136/heartjnl-2022-321907.
4
Absolute coronary flow and microvascular resistance before and after transcatheter aortic valve implantation.经导管主动脉瓣植入术前和术后的绝对冠状动脉血流和微血管阻力。
EuroIntervention. 2024 Oct 7;20(19):e1248-e1528. doi: 10.4244/EIJ-D-24-00075.
5
Coronary Flow Reserve and Myocardial Resistance Reserve Changes After Transcatheter Aortic Valve Implantation in Aortic Stenosis.经导管主动脉瓣置换术治疗主动脉瓣狭窄后冠状动脉血流储备和心肌阻力储备的变化。
Am J Cardiol. 2024 Mar 1;214:109-114. doi: 10.1016/j.amjcard.2024.01.005. Epub 2024 Jan 15.
6
Functional Assessment of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation: Influence of Pressure Overload on the Evaluation of Lesions Severity.经导管主动脉瓣植入术患者冠状动脉疾病的功能评估:压力超负荷对病变严重程度评估的影响
Circ Cardiovasc Interv. 2016 Nov;9(11). doi: 10.1161/CIRCINTERVENTIONS.116.004088.
7
Coronary Physiological Indexes to Evaluate Myocardial Ischemia in Patients With Aortic Stenosis Undergoing Valve Replacement.评估行瓣膜置换术的主动脉瓣狭窄患者心肌缺血的冠状动脉生理指标
JACC Cardiovasc Interv. 2025 Jan 27;18(2):201-212. doi: 10.1016/j.jcin.2024.10.024. Epub 2024 Oct 28.
8
SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI).在接受经导管主动脉瓣植入术(TAVI)的伴有严重主动脉瓣狭窄和心脏损伤的糖尿病患者中使用 SGLT2 抑制剂。
Cardiovasc Diabetol. 2024 Nov 21;23(1):420. doi: 10.1186/s12933-024-02504-8.
9
Association between coronary flow and aortic stenosis during transcatheter aortic valve implantation.经导管主动脉瓣植入术中冠状动脉血流与主动脉瓣狭窄的关系。
ESC Heart Fail. 2023 Jun;10(3):2031-2041. doi: 10.1002/ehf2.14316. Epub 2023 Apr 13.
10
Prognostic Implications of Microvascular Resistance Reserve in Symptomatic Patients With Intermediate Coronary Stenosis.症状性中度冠状动脉狭窄患者微血管阻力储备的预后意义。
JACC Cardiovasc Interv. 2024 Mar 25;17(6):786-797. doi: 10.1016/j.jcin.2024.01.008.

引用本文的文献

1
Sodium-Glucose Cotransporter 2 Inhibitors in Aortic Stenosis: Toward a Comprehensive Cardiometabolic Approach.钠-葡萄糖协同转运蛋白2抑制剂在主动脉瓣狭窄中的应用:迈向全面的心脏代谢治疗方法
Int J Mol Sci. 2025 May 8;26(10):4494. doi: 10.3390/ijms26104494.
2
SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI).在接受经导管主动脉瓣植入术(TAVI)的伴有严重主动脉瓣狭窄和心脏损伤的糖尿病患者中使用 SGLT2 抑制剂。
Cardiovasc Diabetol. 2024 Nov 21;23(1):420. doi: 10.1186/s12933-024-02504-8.
3
Absolute coronary flow and microvascular resistance before and after transcatheter aortic valve implantation.经导管主动脉瓣植入术前和术后的绝对冠状动脉血流和微血管阻力。
EuroIntervention. 2024 Oct 7;20(19):e1248-e1528. doi: 10.4244/EIJ-D-24-00075.
4
Acute changes in microvascular resistance after treating aortic stenosis.治疗主动脉瓣狭窄后微血管阻力的急性变化。
EuroIntervention. 2024 Mar 4;20(5):e274-e275. doi: 10.4244/EIJ-E-23-00068.
5
Invasive Assessment of Coronary Microcirculation: A State-of-the-Art Review.冠状动脉微循环的有创评估:最新综述
Diagnostics (Basel). 2023 Dec 30;14(1):86. doi: 10.3390/diagnostics14010086.

经 TAVI 治疗的重度主动脉瓣狭窄患者的冠状动脉微血管功能障碍特征。

Characterisation of coronary microvascular dysfunction in patients with severe aortic stenosis undergoing TAVI.

机构信息

Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy.

Cardiovascular Center Aalst, OLV-Clinic, Aalst, Belgium.

出版信息

EuroIntervention. 2024 Mar 4;20(5):e289-e300. doi: 10.4244/EIJ-D-23-00735.

DOI:10.4244/EIJ-D-23-00735
PMID:37982178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10905195/
Abstract

BACKGROUND

Microvascular resistance reserve (MRR) is a validated measure of coronary microvascular function independent of epicardial resistances.

AIMS

We sought to assess whether MRR is associated with adverse cardiac remodelling, a low-flow phenotype and extravalvular cardiac damage (EVCD) in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI).

METHODS

Invasive thermodilution-based assessment of the coronary microvascular function of the left anterior descending artery was performed in a prospective, multicentre cohort of patients undergoing TAVI. Coronary microvascular dysfunction (CMD) was defined as the lowest MRR tertile of the study cohort. Haemodynamic measurements were performed at baseline and then repeated immediately after TAVI. EVCD and markers of a low-flow phenotype were assessed with echocardiography.

RESULTS

A total of 134 patients were included in this study. Patients with low MRR were more frequently females, had a lower estimated glomerular filtration rate and a higher rate of atrial fibrillation. MRR was significantly lower in patients with advanced EVCD (median 1.80 [1.26-3.30] vs 2.50 [1.87-3.41]; p=0.038) and in low-flow, low-gradient AS (LF LG-AS) (median 1.85 [1.20-3.04] vs 2.50 [1.87-3.40]; p=0.008). Overall, coronary microvascular function tended to improve after TAVI and, in particular, MRR increased significantly after TAVI in the subgroup with low MRR at baseline. However, MRR was significantly impaired in 38 (28.4%) patients immediately after TAVI. Advanced EVCD (adjusted odds ratio 3.08 [1.22-7.76]; p=0.017) and a low-flow phenotype (adjusted odds ratio 3.36 [1.08-10.47]; p=0.036) were significant predictors of CMD.

CONCLUSIONS

In this observational, hypothesis-generating study, CMD was associated with extravalvular cardiac damage and a low-flow phenotype in patients with severe AS undergoing TAVI.

摘要

背景

微血管阻力储备(MRR)是一种独立于心外膜阻力的冠状动脉微血管功能的验证性测量方法。

目的

我们旨在评估 MRR 是否与严重主动脉瓣狭窄(AS)患者行经导管主动脉瓣置换术(TAVI)后的不良心脏重构、低血流表型和瓣周心脏损伤(EVCD)相关。

方法

前瞻性、多中心队列研究对行 TAVI 的患者进行了左前降支的冠状动脉微血管功能的有创热稀释评估。冠状动脉微血管功能障碍(CMD)定义为研究队列中最低的 MRR 三分位数。在基线时进行血流动力学测量,然后在 TAVI 后立即重复测量。通过超声心动图评估 EVCD 和低血流表型的标志物。

结果

共有 134 例患者纳入本研究。MRR 较低的患者更常为女性,估算肾小球滤过率较低,心房颤动发生率较高。在晚期 EVCD(中位数 1.80 [1.26-3.30] vs 2.50 [1.87-3.41];p=0.038)和低流量、低梯度 AS(LF LG-AS)(中位数 1.85 [1.20-3.04] vs 2.50 [1.87-3.40];p=0.008)患者中,MRR 显著降低。总的来说,冠状动脉微血管功能在 TAVI 后趋于改善,特别是在基线时 MRR 较低的亚组中,TAVI 后 MRR 显著增加。然而,在 TAVI 后,有 38 名(28.4%)患者的 MRR 显著受损。晚期 EVCD(调整后的优势比 3.08 [1.22-7.76];p=0.017)和低血流表型(调整后的优势比 3.36 [1.08-10.47];p=0.036)是 CMD 的显著预测因素。

结论

在这项观察性、产生假说的研究中,CMD 与严重 AS 患者行 TAVI 后的瓣周心脏损伤和低血流表型相关。